We review our content at regular intervals and update it whenever new research or a change in clinical guidelines requires it.
| FIELD OF APPLICATION | DETAILS |
|---|---|
| Generic Name | Dimetotiazine |
| Active Ingredient | Fonazine mesylate |
| Drug Category | Neurology |
| Drug Class | Palliative treatment, Immunosuppressive therapy, Targeted therapy |
| FDA Approval Status | Not approved |
Dimetotiazine: Overview
Dimetotiazine (also known as fonazine mesylate or dimethothiazine) is a polycyclic aromatic compound belonging to the phenothiazine class. It exhibits strong histamine H1 receptor and serotonin 5-HT2 receptor antagonistic properties, along with antiemetic effects. Historically, dimetotiazine has been utilized internationally in neurology and dermatology for allergic skin conditions, tension headaches, and the prophylaxis and treatment of migraine.
What Is Dimetotiazine & How Does It Work?
Dimetotiazine belongs to the class of organic compounds known as phenothiazines, featuring a linear tricyclic system consisting of two benzene rings joined by a para-thiazine ring. Chemically, it functions as a small molecule organosulfonamide and alkyldiarylamine derivative.
The primary mechanism of action of dimetotiazine relies on its dual activity as a potent Histamine H1 receptor antagonist and a 5-hydroxytryptamine (serotonin) receptor 2 (5-HT2) antagonist. By blocking Histamine H1 receptors on effector cells, it alleviates allergic responses, reduces capillary permeability, and suppresses pruritus in allergic skin conditions. Through its selective antagonism of central and peripheral 5-HT2 receptors, dimetotiazine inhibits serotonin-mediated vascular tone fluctuations and cerebral vasoconstriction, which provides its antimigraine and analgesic effects. Additionally, it possesses mild central anticholinergic and antiemetic properties characteristic of phenothiazine derivatives.
Is Dimetotiazine FDA Approved?
Dimetotiazine is Not Approved by the U.S. Food and Drug Administration (FDA) for commercial distribution or prescription use in the United States.
Historically, dimetotiazine mesylate was approved and marketed internationally in Europe under trade names such as Migristene for oral migraine prophylaxis and allergic dermatoses. However, it has largely been superseded by modern selective migraine therapies such as triptans and CGRP antagonists and is no longer widely authorized or routinely marketed in major clinical jurisdictions.
What Is Dimetotiazine Used For?
While not FDA approved in the United States, dimetotiazine has historical and international clinical utility in neurological and dermatological care.
- Migraine Prophylaxis & Treatment: Prescribed internationally as an oral agent to prevent cerebral vasoconstriction and mitigate the onset of migraine and tension headaches (Not FDA Approved).
- Allergic Skin Conditions: Utilized as an antihistaminic and anti-serotonergic agent to manage severe itching, urticaria, and inflammatory allergic dermatoses (Not FDA Approved).
- Antiemetic Support: Applied for its palliative properties to control mild nausea and vomiting associated with central neurotransmitter fluctuations (Not FDA Approved).
Before Taking Dimetotiazine: Contraindications & Precautions
Clinicians must review a patient’s cardiovascular and central nervous system status before considering phenothiazine antihistamines. Proper evaluation minimizes the risk of severe sedation and anticholinergic complications.
Who Should Not Take Dimetotiazine?
Dimetotiazine is contraindicated in individuals with known hypersensitivity to phenothiazine derivatives or fonazine mesylate. It should not be used in patients with severe bone marrow suppression, closed-angle glaucoma, severe urinary retention, or pre-existing severe cardiovascular disorders.
Dimetotiazine: Pregnancy & Fertility
The safety and teratogenic profile of dimetotiazine during human pregnancy have not been established in comprehensive clinical trials. Due to potential extrapyramidal and sedative effects on the fetus, it should be avoided during pregnancy and lactation unless explicitly evaluated by a specialist.
Tell Your Doctor Before Taking Dimetotiazine
Inform your healthcare provider if you have a history of epilepsy, severe hepatic impairment, cardiac arrhythmias, or prostatic hypertrophy. Disclose all concurrent medications, particularly central nervous system depressants, antihypertensives, and drugs that prolong the QTc interval.
Dimetotiazine: Dosage & Administration
Standardized clinical dosing protocols for dimetotiazine depend on historical international product labels.
Standard Dimetotiazine Dosing
When historically prescribed for oral migraine prophylaxis or allergic skin disorders, adult dosages of dimetotiazine mesylate typically ranged from 20 mg to 50 mg daily, divided into multiple smaller doses. Standardized prescription dosage forms are unavailable in US pharmaceutical channels.
How Dimetotiazine Is Administered
Dimetotiazine is administered orally in tablet form. Taking the medication alongside food or meals helps reduce potential gastrointestinal irritation.
Dimetotiazine: Clinical Efficacy & Research
Historical clinical research in Europe demonstrated that dimetotiazine effectively reduces the frequency and duration of vascular headaches through its combined anti-serotonergic and antihistaminic actions. Its ability to stabilize vascular tone helped prevent cerebral vasospasms. However, modern systematic reviews highlight that its clinical utility is limited by phenothiazine-related side effects, such as drowsiness and anticholinergic dryness. Consequently, contemporary headache management relies heavily on targeted receptor agonists like triptans or modern CGRP antagonists rather than non-selective phenothiazines.
Dimetotiazine: Side Effects & Safety Profile
This medication does not have an FDA Black Box Warning, as it is not an FDA-approved drug in the United States.
The adverse event profile of dimetotiazine reflects its phenothiazine structure and multi-receptor binding activity.
Common Dimetotiazine Side Effects
Common adverse effects include central nervous system depression, marked drowsiness, sedation, dry mouth, blurred vision, dizziness, and mild gastrointestinal discomfort.
Serious Dimetotiazine Adverse Events
Serious adverse events associated with phenothiazine derivatives include extrapyramidal symptoms (such as muscle rigidity or dystonia), orthostatic hypotension, cardiac arrhythmias, QTc prolongation, cholestatic jaundice, and rare blood dyscrasias.
Managing Dimetotiazine Side Effects
Patients experiencing mild sedation should avoid driving or operating machinery. If extrapyramidal signs, severe dizziness, or signs of cardiovascular instability occur, discontinue the drug immediately and seek emergency medical care.
Dimetotiazine: Interactions & What to Avoid
Dimetotiazine exhibits significant pharmacological interactions due to its actions on central histamine, serotonin, and autonomic pathways.
Dimetotiazine: Interactions
Co-administering dimetotiazine with other central nervous system depressants (such as benzodiazepines, opioids, or sedating antihistamines) produces additive hypnotic and sedative toxicity. Combining it with medications known to prolong the QTc interval increases the risk of dangerous ventricular arrhythmias. It can also potentiate the hypotensive effects of antihypertensive agents.
Dimetotiazine: Food & Alcohol
Taking dimetotiazine with food minimizes stomach upset. Alcohol consumption must be strictly avoided, as alcohol significantly compounds phenothiazine-induced central nervous system depression, dizziness, and motor impairment.
Dimetotiazine: Missed Dose, Overdose & Storage
Appropriate storage and handling protocols help ensure chemical stability and prevent accidental poisoning.
Missed Dose of Dimetotiazine
If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. Do not take a double dose to make up for a missed tablet.
Dimetotiazine: Overdose & Emergency
An overdose of dimetotiazine produces severe central nervous system depression, deep coma, severe hypotension, hypothermia, extrapyramidal reactions, and cardiac arrhythmias. Emergency management requires immediate supportive care, continuous cardiac monitoring, airway protection, and symptomatic fluid resuscitation.
How to Store Dimetotiazine
Store tablets at controlled room temperature between 20°C and 25°C (68°F to 77°F) away from moisture, heat, and direct light exposure. Keep containers tightly closed and out of reach of children.
Dimetotiazine: Patient Management & Monitoring
Continuous medical oversight ensures that patients using historical phenothiazines avoid unrecognized cardiovascular or neurological toxicity.
Tests Before Starting Dimetotiazine
Prior to initiating dimetotiazine therapy, healthcare providers should obtain baseline blood counts, liver function panels, and an electrocardiogram (ECG) to assess baseline QTc intervals.
Monitoring During Dimetotiazine Treatment
Patients require routine monitoring of blood pressure, heart rate, hepatic function, and signs of extrapyramidal side effects or excessive sedation.
Dimetotiazine: Do’s and Don’ts
- Do take oral doses with food if you experience stomach upset.
- Don’t consume alcohol or drive a vehicle while taking dimetotiazine due to strong sedating effects.
Frequently Asked Questions
What is Dimetotiazine used for?
Dimetotiazine has considerable antiemetic and serotonin antagonistic action used mainly in allergic skin conditions.
Is Dimetotiazine FDA approved in the United States?
No, Dimetotiazine is Not Approved by the U.S. FDA for clinical use or prescription distribution.
How does Dimetotiazine work?
It acts as a Histamine H1 receptor antagonist and a 5-hydroxytryptamine receptor 2 antagonist.
Does Dimetotiazine have an FDA Black Box Warning?
This medication does not have an FDA Black Box Warning because it is not an FDA-regulated drug in the United States.
What class of organic compounds does Dimetotiazine belong to?
It belongs to the class of organic compounds known as phenothiazines, which feature a linear tricyclic system consisting of two benzene rings joined by a para-thiazine ring.
What is the active ingredient in Dimetotiazine?
The active ingredient associated with this compound is fonazine mesylate.
References
- DrugBank Online. Dimetotiazine (DB08967).
- Medthority. Migristene (dimetotiazine mesylate) Profile.
- National Center for Advancing Translational Sciences (NCATS). Inxight Drugs: Fonazine Mesylate.
Legal Disclaimer
The information provided is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider at any hospital or any local clinic before starting or stopping any medication.
